Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Frequency distributions of clinicopathological variables

From: Identification of prognostic factors and surgical indications for metastatic gastric cancer

Variable Whole group (n = 123) Resection group (n = 83) Non-resection group (n = 40) p value
Patient data     
Age (years)     
  ≤ 65 57 (46) 37 (45) 20 (50) 0.670
  >65 66 (54) 46 (55) 20 (50)
Sex     
  Female 38 (31) 29 (35) 9 (22) 0.212
  Male 85 (69) 54 (65) 31 (78)
PS     
  0 46 (37) 40 (48) 6 (15) < 0.001
  1 47 (38) 34 (41) 13 (33)
  2 20 (16) 9 (11) 12 (30)
  3 10 (9) 0 9 (22)
Body mass index (kg/m2)     
  ≤ 21 62 (50) 41 (49) 19 (47) 0.848
  >21 61 (50) 42 (51) 21 (33)
Primary tumor data     
Location in stomach     
  Lower 31 (25) 24 (29) 7 (18) 0.058
  Middle 33 (27) 26 (31) 7 (18)
  Upper 37 (30) 22 (27) 15 (37)
  Whole 22 (18) 11 (13) 11 (27)
Histological differentiation     
  Differentiated 45 (37) 33 (40) 12 (30) 0.324
  Undifferentiated 78 (63) 50 (60) 28 (70)
Adjacent organ invasion     
  Present 32 (26) 11 (13) 21 (52) < 0.001
  Absent 91 (74) 72 (87) 19 (48)
Bulky lymph nodes     
  Present 75 (61) 46 (55) 21 (52) 0.079
  Absent 48 (39) 37 (45) 19 (48)
Laboratory data     
CEA (ng/mL)     
  ≤ 6 76 (62) 49 (59) 27 (68) 0.431
  >6 47 (38) 34 (41) 13 (32)
CA19-9 (U/mL)     
  ≤ 37 75 (61) 55 (66) 20 (50) 0.114
  >37 48 (39) 28 (34) 20 (50)
NLR     
  ≤ 3.1 64 (52) 46 (55) 18 (45) 0.337
  >3.1 59 (48) 37 (45) 22 (55)
Hb (g/dL)     
  ≤ 12 64 (52) 44 (53) 20 (50) 0.114
  >12 59 (48) 39 (47) 20 (50)
CRP (mg/dL)     
  ≤ 0.2 58 (47) 44 (53) 14 (35) 0.083
  >0.2 65 (53) 39 (47) 26 (65)
Alb (g/dL)     
  ≤ 3.5 50 (41) 29 (35) 21 (52) 0.079
  >3.5 73 (59) 54 (65) 19 (48)
Metastatic tumor data     
Number of organs involved     
  1 74 (60) 53 (64) 21 (52) 0.244
  ≥2 49 (40) 30 (36) 19 (48)
Peritoneal metastasis     
  Yes 66 (54) 42 (51) 24 (60) 0.343
  No 57 (46) 41 (49) 16 (40)
Distant nodal metastasis     
  Yes 55 (45) 30 (36) 25 (62) 0.007
  No 68 (55) 53 (64) 15 (38)
Hepatic metastasis     
  Yes 40 (33) 31 (37) 9 (23) 0.107
  No 83 (67) 52 (63) 31 (77)
Surgical data     
Metastasectomy     
  Yes 28 (23) 28 (34)  
  No 95 (77) 55 (66)
Site of metastasectomy    
  Peritoneum   16  
  Lymph node   2
  Liver   10 -–
Chemotherapy     
  Yes 98 (80) 64 (77) 34 (85) 0.349
  No 25 (20) 19 (23) 6 (15)
Chemotherapy before surgery     
  Yes   23 (28)  
  No   60 (72)
Chemotherapy after surgery     
  Yes   64 (77)  
  No   19 (23)